Millennium Licenses BioRS System from Biomax for In-House Data Integration; Biomax Teams Up With Molecular Networks | GenomeWeb

NEW YORK, July 9 - Millennium Pharmaceuticals has agreed to license the BioRS data integration and retrieval system from Biomax, the companies said Monday. 

BioRS integrates public and proprietary biological databases through a web interface. The system uses XML to standardize the data format, and can integrate both relational and flat-file databases. In January, Informax signed a four-year deal with Biomax, based in Martinsried, to exclusively license and distribute the BioRS system worldwide.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.